The economic and societal burden of excessive daytime sleepiness in patients with obstructive sleep apnea
- PMID: 32169792
- DOI: 10.1016/j.smrv.2020.101275
The economic and societal burden of excessive daytime sleepiness in patients with obstructive sleep apnea
Abstract
Excessive daytime sleepiness (EDS) is common in patients with obstructive sleep apnea (OSA) and continues to persist in many patients despite adequate OSA treatment. EDS in OSA is associated with decreased quality of life (QOL) as well as increased societal burden, which may impact health care utilization and costs. However, economic burden is often not the primary focus in the treatment of EDS in OSA. This targeted literature review aimed to examine the published literature on the economic burden of EDS in OSA. This review identified available literature using a targeted PubMed search strategy using search terms related to EDS in OSA in adults. Results demonstrate that there are few studies that detailed the direct costs associated with EDS in OSA, though several studies indicated an association between EDS in OSA and indirect economic burdens, including motor vehicle accidents (MVAs), near misses, work productivity, mood, and QOL. Data from the literature confirmed that persistent EDS in OSA following continuous positive airway pressure persists in 12%-65% of patients. Future studies should further describe the direct costs of EDS in OSA, quantify the cost associated with MVAs and lost work productivity, and detail QOL and social impacts of the condition.
Keywords: Economic burden; Excessive daytime sleepiness; Health care utilization; Motor vehicle accident; Obstructive sleep apnea; Quality of life; Work productivity.
Copyright © 2020 The Author(s). Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
Conflicts of interest D. Léger: Dr. Damien Léger is or has been consulted as the main investigator in studies sponsored by Actelion, Agence Spatiale Européenne, Ag2R, Bioprojet, CNES, DGA, iSommeil, Jazz, Vanda, Merck, NASA, Philips, ResMed, Sanofi, Rhythm, Vinci Foundation, and VitalAire in the last five years. He declares no conflict of interest in relation to this manuscript. C. Stepnowsky: Dr. Carl Stepnowsky has no disclosures to report.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources